MEDICLIN Aktiengesellschaft
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, vascular medicine, otorhinolaryngology, cardiac medicine, rheumatology, pain medicine, trauma surgery, urology, a… Read more
MEDICLIN Aktiengesellschaft (MED) - Net Assets
Latest net assets as of September 2025: €248.10 Million EUR
Based on the latest financial reports, MEDICLIN Aktiengesellschaft (MED) has net assets worth €248.10 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€910.59 Million) and total liabilities (€662.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €248.10 Million |
| % of Total Assets | 27.25% |
| Annual Growth Rate | 3.95% |
| 5-Year Change | 25.95% |
| 10-Year Change | 31.69% |
| Growth Volatility | 11.37 |
MEDICLIN Aktiengesellschaft - Net Assets Trend (2003–2024)
This chart illustrates how MEDICLIN Aktiengesellschaft's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MEDICLIN Aktiengesellschaft (2003–2024)
The table below shows the annual net assets of MEDICLIN Aktiengesellschaft from 2003 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €222.74 Million | +13.62% |
| 2023-12-31 | €196.03 Million | -6.35% |
| 2022-12-31 | €209.32 Million | +14.37% |
| 2021-12-31 | €183.02 Million | +3.49% |
| 2020-12-31 | €176.85 Million | -7.29% |
| 2019-12-31 | €190.75 Million | -0.34% |
| 2018-12-31 | €191.40 Million | +3.32% |
| 2017-12-31 | €185.26 Million | +2.04% |
| 2016-12-31 | €181.56 Million | +7.35% |
| 2015-12-31 | €169.14 Million | +9.87% |
| 2014-12-31 | €153.95 Million | +1.16% |
| 2013-12-31 | €152.19 Million | -3.08% |
| 2012-12-31 | €157.02 Million | -5.17% |
| 2011-12-31 | €165.59 Million | +0.37% |
| 2010-12-31 | €164.99 Million | +4.91% |
| 2009-12-31 | €157.26 Million | +5.66% |
| 2008-12-31 | €148.84 Million | +42.88% |
| 2007-12-31 | €104.17 Million | +5.82% |
| 2006-12-31 | €98.44 Million | +12.08% |
| 2005-12-31 | €87.83 Million | +7.84% |
| 2004-12-31 | €81.45 Million | -17.56% |
| 2003-12-31 | €98.80 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to MEDICLIN Aktiengesellschaft's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5265111300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €8.47 Million | 3.81% |
| Common Stock | €47.50 Million | 21.35% |
| Other Comprehensive Income | €48.00K | 0.02% |
| Other Components | €166.49 Million | 74.82% |
| Total Equity | €222.51 Million | 100.00% |
MEDICLIN Aktiengesellschaft Competitors by Market Cap
The table below lists competitors of MEDICLIN Aktiengesellschaft ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shalby Limited
NSE:SHALBY
|
$42.51 Million |
|
TOPMATERIAL LTD
KQ:360070
|
$42.52 Million |
|
Chitec Technology Co., Ltd.
TWO:3430
|
$42.53 Million |
|
Associated Capital Group Inc
NYSE:AC
|
$42.54 Million |
|
Puloon Technology Inc
KQ:094940
|
$42.50 Million |
|
Condor Gold Plc
PINK:CNDGF
|
$42.50 Million |
|
Deep Noid Inc.
KQ:315640
|
$42.49 Million |
|
Usak Seramik Sanayi AS
IS:USAK
|
$42.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEDICLIN Aktiengesellschaft's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 195,917,976 to 222,506,055, a change of 26,588,079 (13.6%).
- Net income of 24,839,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 35,345,431.
- Other factors increased equity by 37,094,510.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €24.84 Million | +11.16% |
| Other Comprehensive Income | €-35.35 Million | -15.89% |
| Other Changes | €37.09 Million | +16.67% |
| Total Change | €- | 13.57% |
Book Value vs Market Value Analysis
This analysis compares MEDICLIN Aktiengesellschaft's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.77x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.15x to 0.77x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | €3.14 | €3.62 | x |
| 2004-12-31 | €2.69 | €3.62 | x |
| 2005-12-31 | €2.77 | €3.62 | x |
| 2006-12-31 | €3.13 | €3.62 | x |
| 2007-12-31 | €3.25 | €3.62 | x |
| 2008-12-31 | €4.59 | €3.62 | x |
| 2009-12-31 | €3.31 | €3.62 | x |
| 2010-12-31 | €3.47 | €3.62 | x |
| 2011-12-31 | €3.49 | €3.62 | x |
| 2012-12-31 | €3.31 | €3.62 | x |
| 2013-12-31 | €3.21 | €3.62 | x |
| 2014-12-31 | €3.25 | €3.62 | x |
| 2015-12-31 | €3.57 | €3.62 | x |
| 2016-12-31 | €3.83 | €3.62 | x |
| 2017-12-31 | €3.91 | €3.62 | x |
| 2018-12-31 | €4.03 | €3.62 | x |
| 2019-12-31 | €4.02 | €3.62 | x |
| 2020-12-31 | €3.73 | €3.62 | x |
| 2021-12-31 | €3.86 | €3.62 | x |
| 2022-12-31 | €4.40 | €3.62 | x |
| 2023-12-31 | €4.12 | €3.62 | x |
| 2024-12-31 | €4.68 | €3.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MEDICLIN Aktiengesellschaft utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.16%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.32%
- • Asset Turnover: 0.83x
- • Equity Multiplier: 4.07x
- Recent ROE (11.16%) is above the historical average (1.73%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -17.16% | -4.51% | 0.99x | 3.84x | €-26.84 Million |
| 2004 | -19.53% | -4.44% | 0.99x | 4.44x | €-24.05 Million |
| 2005 | 9.21% | 2.10% | 1.38x | 3.18x | €-671.05K |
| 2007 | 5.50% | 1.46% | 1.45x | 2.59x | €-4.69 Million |
| 2008 | 4.89% | 1.59% | 1.33x | 2.31x | €-7.61 Million |
| 2009 | 6.59% | 2.20% | 1.41x | 2.12x | €-5.37 Million |
| 2010 | 6.12% | 2.07% | 1.45x | 2.04x | €-6.39 Million |
| 2011 | 1.80% | 0.60% | 1.50x | 1.99x | €-13.58 Million |
| 2012 | -0.89% | -0.28% | 1.59x | 2.03x | €-17.11 Million |
| 2013 | -1.73% | -0.51% | 1.65x | 2.05x | €-17.88 Million |
| 2014 | 5.51% | 1.58% | 1.68x | 2.07x | €-6.93 Million |
| 2015 | 9.76% | 2.98% | 1.69x | 1.94x | €-412.85K |
| 2016 | 9.10% | 2.85% | 1.67x | 1.91x | €-1.64 Million |
| 2017 | 2.11% | 0.64% | 1.65x | 1.99x | €-14.65 Million |
| 2018 | 4.03% | 1.20% | 1.45x | 2.32x | €-11.44 Million |
| 2019 | 5.06% | 1.44% | 0.75x | 4.70x | €-9.44 Million |
| 2020 | -5.08% | -1.36% | 0.74x | 5.01x | €-26.71 Million |
| 2021 | 0.80% | 0.22% | 0.76x | 4.81x | €-16.87 Million |
| 2022 | 4.51% | 1.34% | 0.77x | 4.38x | €-11.48 Million |
| 2023 | -5.50% | -1.48% | 0.83x | 4.49x | €-30.37 Million |
| 2024 | 11.16% | 3.32% | 0.83x | 4.07x | €2.59 Million |
Industry Comparison
This section compares MEDICLIN Aktiengesellschaft's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,542,527,848
- Average return on equity (ROE) among peers: 7.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEDICLIN Aktiengesellschaft (MED) | €248.10 Million | -17.16% | 2.67x | $42.51 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |